Neoprobe Corporation develops and commercializes biomedical products. The company produces devices to meet the intra-operative, diagnostic and therapeutic treatment needs of patients and physicians. It focuses on the use of gamma-detection systems in combination with radiopharmaceutical agents to improve cancer surgery outcomes. Through Cardiosonix, Neoprobe has developed the Quantix line of blood flow measurement products for a variety of clinical needs, including real-time monitoring, intra-operative quantification, non-invasive diagnostics and blood flow evaluation. The company s Cira Biosciences unit explores activated cellular technology for the potential treatment of viral and autoimmune diseases. Neoprobe Corporation is headquartered in Dublin, Ohio.
Partial Data by Infogroup (c) 2024. All rights reserved.
Partial Data by Foursquare.